BIOMAT Database Logo BIOMAT Database Logo

Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy. 1998

T G Gross, and S H Hinrichs, and J Winner, and T C Greiner, and S S Kaufman, and P H Sammut, and A N Langnas

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D008297 Male Males
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T G Gross, and S H Hinrichs, and J Winner, and T C Greiner, and S S Kaufman, and P H Sammut, and A N Langnas
Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
October 2005, Critical reviews in oncology/hematology,
T G Gross, and S H Hinrichs, and J Winner, and T C Greiner, and S S Kaufman, and P H Sammut, and A N Langnas
CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation.
February 2007, Haematologica,
T G Gross, and S H Hinrichs, and J Winner, and T C Greiner, and S S Kaufman, and P H Sammut, and A N Langnas
CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation.
March 2011, British journal of haematology,
T G Gross, and S H Hinrichs, and J Winner, and T C Greiner, and S S Kaufman, and P H Sammut, and A N Langnas
Post-transplant lymphoproliferative disorders following solid-organ transplantation.
February 2010, Expert review of hematology,
T G Gross, and S H Hinrichs, and J Winner, and T C Greiner, and S S Kaufman, and P H Sammut, and A N Langnas
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
September 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T G Gross, and S H Hinrichs, and J Winner, and T C Greiner, and S S Kaufman, and P H Sammut, and A N Langnas
Low-dose chemotherapy for children with post-transplant lymphoproliferative disease.
January 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
T G Gross, and S H Hinrichs, and J Winner, and T C Greiner, and S S Kaufman, and P H Sammut, and A N Langnas
Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.
January 1998, Springer seminars in immunopathology,
T G Gross, and S H Hinrichs, and J Winner, and T C Greiner, and S S Kaufman, and P H Sammut, and A N Langnas
Post-transplant lymphoproliferative disorder (PTLD).
March 2007, Clinical oncology (Royal College of Radiologists (Great Britain)),
T G Gross, and S H Hinrichs, and J Winner, and T C Greiner, and S S Kaufman, and P H Sammut, and A N Langnas
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation.
January 2021, Leukemia & lymphoma,
T G Gross, and S H Hinrichs, and J Winner, and T C Greiner, and S S Kaufman, and P H Sammut, and A N Langnas
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
October 2022, Leukemia,
Copied contents to your clipboard!